This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pharmacological actions

Authoring team

MAOI's inactivate the enzymes that oxidise noradrenaline, 5-HT, tyramine, and other amines which are widely distributed in the body as transmitters, or taken in food and drink, or as drugs. These drugs also inhibit hydroxylases in the liver, which in turn serves to inhibit the metabolism of substances such as barbiturates, tricyclic anti-depressants, phenytoin, alcohol and anti-parkisonian drugs.

The inhibition of monoamine oxidase occurs quickly, but on withdrawal it may take as long as two weeks before the enzyme is back to its previous level of activity.

MAOIs also have several autonomic side effects whose precise mechanisms are not clear: e.g. orthostatic hypotension, dry mouth, blurred vision, constipation, ankle oedema, delayed micturition and ejaculation.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.